vs
Side-by-side financial comparison of Incyte (INCY) and RENAISSANCERE HOLDINGS LTD (RNR). Click either name above to swap in a different company.
RENAISSANCERE HOLDINGS LTD is the larger business by last-quarter revenue ($2.2B vs $1.3B, roughly 1.7× Incyte). Incyte runs the higher net margin — 23.8% vs 23.5%, a 0.3% gap on every dollar of revenue. On growth, Incyte posted the faster year-over-year revenue change (20.9% vs -36.8%). Over the past eight quarters, Incyte's revenue compounded faster (10.4% CAGR vs -11.9%).
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
RenaissanceRe Holdings Ltd is a Bermudian provider of reinsurance, insurance and other related business services. The company operates in reinsurance, insurance and ventures.
INCY vs RNR — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $2.2B |
| Net Profit | $303.3M | $515.8M |
| Gross Margin | — | — |
| Operating Margin | 23.7% | — |
| Net Margin | 23.8% | 23.5% |
| Revenue YoY | 20.9% | -36.8% |
| Net Profit YoY | 91.7% | 72.6% |
| EPS (diluted) | $1.47 | $6.57 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $2.2B | ||
| Q4 25 | $1.5B | $3.0B | ||
| Q3 25 | $1.4B | $3.2B | ||
| Q2 25 | $1.2B | $3.2B | ||
| Q1 25 | $1.1B | $3.5B | ||
| Q4 24 | $1.2B | $2.3B | ||
| Q3 24 | $1.1B | $4.0B | ||
| Q2 24 | $1.0B | $2.8B |
| Q1 26 | $303.3M | $515.8M | ||
| Q4 25 | $299.3M | $760.5M | ||
| Q3 25 | $424.2M | $916.5M | ||
| Q2 25 | $405.0M | $835.4M | ||
| Q1 25 | $158.2M | $170.0M | ||
| Q4 24 | $201.2M | $-189.7M | ||
| Q3 24 | $106.5M | $1.2B | ||
| Q2 24 | $-444.6M | $503.9M |
| Q1 26 | — | — | ||
| Q4 25 | 92.0% | — | ||
| Q3 25 | 92.8% | — | ||
| Q2 25 | 93.5% | — | ||
| Q1 25 | 93.0% | — | ||
| Q4 24 | 92.5% | — | ||
| Q3 24 | 92.4% | — | ||
| Q2 24 | 92.7% | — |
| Q1 26 | 23.7% | — | ||
| Q4 25 | 22.3% | 42.5% | ||
| Q3 25 | 32.5% | 46.3% | ||
| Q2 25 | 43.6% | 41.8% | ||
| Q1 25 | 19.5% | -2.0% | ||
| Q4 24 | 25.6% | -3.6% | ||
| Q3 24 | 12.8% | 43.7% | ||
| Q2 24 | -45.8% | 25.0% |
| Q1 26 | 23.8% | 23.5% | ||
| Q4 25 | 19.9% | 25.6% | ||
| Q3 25 | 31.1% | 28.7% | ||
| Q2 25 | 33.3% | 26.1% | ||
| Q1 25 | 15.0% | 4.9% | ||
| Q4 24 | 17.1% | -8.3% | ||
| Q3 24 | 9.4% | 29.8% | ||
| Q2 24 | -42.6% | 17.8% |
| Q1 26 | $1.47 | $6.57 | ||
| Q4 25 | $1.46 | $16.16 | ||
| Q3 25 | $2.11 | $19.40 | ||
| Q2 25 | $2.04 | $17.20 | ||
| Q1 25 | $0.80 | $3.27 | ||
| Q4 24 | $0.90 | $-3.76 | ||
| Q3 24 | $0.54 | $22.62 | ||
| Q2 24 | $-2.04 | $9.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.6B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $5.6B | $4.3B |
| Total Assets | $7.3B | $53.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.6B | ||
| Q4 25 | $3.1B | $1.7B | ||
| Q3 25 | $2.5B | $1.7B | ||
| Q2 25 | $2.0B | $1.4B | ||
| Q1 25 | $1.9B | $1.6B | ||
| Q4 24 | $1.7B | $1.7B | ||
| Q3 24 | $1.3B | $1.6B | ||
| Q2 24 | $987.3M | $1.6B |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.3B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | — | $2.3B | ||
| Q1 25 | — | $2.8B | ||
| Q4 24 | — | $1.9B | ||
| Q3 24 | — | $1.9B | ||
| Q2 24 | — | $2.0B |
| Q1 26 | $5.6B | $4.3B | ||
| Q4 25 | $5.2B | $11.6B | ||
| Q3 25 | $4.7B | $11.5B | ||
| Q2 25 | $4.2B | $10.8B | ||
| Q1 25 | $3.7B | $10.3B | ||
| Q4 24 | $3.4B | $10.6B | ||
| Q3 24 | $3.2B | $11.2B | ||
| Q2 24 | $3.0B | $10.2B |
| Q1 26 | $7.3B | $53.7B | ||
| Q4 25 | $7.0B | $53.8B | ||
| Q3 25 | $6.3B | $54.5B | ||
| Q2 25 | $5.8B | $54.7B | ||
| Q1 25 | $5.7B | $53.6B | ||
| Q4 24 | $5.4B | $50.7B | ||
| Q3 24 | $5.0B | $52.8B | ||
| Q2 24 | $4.7B | $51.6B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.20× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.21× | ||
| Q1 25 | — | 0.27× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.17× | ||
| Q2 24 | — | 0.19× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
